'김갑성' 기자의 전체기사
-
Korea's XR Startup DoubleMe To Reveal Breakthrough AI Tec…
[ 메디채널 김갑성 기자 ] DoubleMe, Korea's leading XR startup, to showcase its Next-Gen XR technologies to the Japanese wellness market in Tokyo this Fall. SEOUL, South Korea, Sept. 23, 2025 -- DoubleMe, a global pioneer in spatial computing and immersive technology, will visit the Autumn 2025 Tokyo XR Fair from October 8 - 10, 2025 to present their latest immersive technologies and share innovative mental health solutions with the Japanese market. DoubleMe plans to serve Japanese locals with XR-based healing experiences compatible with Japan's traditional Zen meditation cult
- 김갑성 기자
- 2025-09-23 09:00
-
With Millions of Children's Lives on the Line, Bill Gates Says Hu…
[ 메디채널 김갑성 기자 ] At 2025 Goalkeepers event, Gates lays out roadmap for saving millions more children's lives by 2045 if governments stretch every dollar and scale a pipeline of affordable, lifesaving innovations Announces new pledge to the Global Fund 2026-2028 replenishment to prevent deaths from AIDS, TB, and malaria Honors President of the Government of Spain with 2025 Global Goalkeeper Award and 10 champions for their ingenuity and resilience, and for offering hope, solutions in the face of steep funding cuts NEW YORK, Sept. 23 2025 -- At its 2025 Goalkeepers event,
- 김갑성 기자
- 2025-09-23 08:00
-
Sweden, the world's first travel destination on prescription
A new research-backed initiative sees physicians recommending trips to Sweden for the health benefits. STOCKHOLM, Sept. 23, 2025 -- A sauna in Swedish Lapland for better sleep quality, or cold plunges in the archipelago for improved circulation? Two out of three respondents in a new international survey would be open to spending more time in nature if a doctor prescribed it. Now, Sweden is positioning itself as the world's first country to which travel can be prescribed by a doctor. Watch how experiences in Sweden can boost health: www.youtube.com/watch?v=hqo3PZwOZhk&nbs
- 김갑성 기자
- 2025-09-23 06:29
-
IMRA Surgical Announces Collaboration with Telix Pharmace…
MELBOURNE, Australia, Sept. 23, 2025 -- IMRA Surgical, an Australian-based company at the forefront of disruptive technology for surgical training solutions announces a collaboration with Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") a global leader in radiopharmaceuticals. Both parties aim to accelerate the development of advanced training models and enhance the integration of cutting-edge radio-guided surgical technologies. Strengthening Surgical Precision with SENSEI® in Robotic-Assisted Surgery Telix's innovative SENSEI&re
- 김갑성 기자
- 2025-09-23 05:19
-
Global Times: China's silver economy unleashes diversifie…
BEIJING, Sept. 22, 2025 -- China is actively addressing the challenges of an aging population. As the senior population grows and their spending habits evolve, the silver economy is emerging as a driver of economic growth and industrial development. From optimizing consumption patterns to expanding emerging industries, from applying smart technologies to improving medical and elderly care services, the silver economy is becoming a new engine propelling multiple sectors forward.Younger seniors are the main force in China's silver economy, and their consumption needs are becoming increasingly d
- 김갑성 기자
- 2025-09-22 21:26
-
Global Times: China's silver economy: innovation, dignity,…
BEIJING, Sept. 22, 2025 -- China's silver economy is not only transforming the lives of its senior citizens but also reshaping the global conversation about how societies should respond to demographic change. With medium-speed growth in per capita consumption, the scale of China's silver economy is projected to reach 19.1 trillion yuan ($2.68 trillion) by 2035, accounting for nearly 28 percent of total consumption, according to the Fudan Institute on Aging. Far from being a passive challenge, aging in China is being actively turned into a source of innovation, new industries, and internationa
- 김갑성 기자
- 2025-09-22 21:20
-
Lunit and Agilent Technologies Announce Collaboration…
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, Sept. 22, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in t
- 김갑성 기자
- 2025-09-22 21:00
-
Galux Demonstrates De Novo Antibody Design With Structural a…
[ 메디채널 김갑성 기자 ] Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody Findings highlight broad therapeutic applicability across oncology, immune, and metabolic diseases SEOUL, South Korea, Sept. 22, 2025 -- Galux, a South Korea–based biotech company pioneering AI-driven protein therapeutics design, today announced new results that further validate its de novo antibody design platform, GaluxDesign. The findings showcase the platform's ability to generate novel antibodies that meet precise st
- 김갑성 기자
- 2025-09-22 21:00
-
Plume Appoints Former NASA Engineer, Startup CTO Mik Cox as S…
Cox brings leadership experience in IoT, smart home, and AI-powered systems to help Plume define and deploy its next wave of market-defining technology for ISPs PALO ALTO, Calif., Sept. 22, 2025 -- Plume today appointed former Ubiety Chief Technology Officer and NASA Jet Propulsion Laboratory (JPL) engineer Mik Cox as Senior Vice President of Technology Innovation. Cox will lead the company's new technology innovation team, which will build upon Plume's legacy of innovation and define and realize its next market-defining technology for customers. With almost half a billion devi
- 김갑성 기자
- 2025-09-22 20:00
-
SOPHiA GENETICS Expands Collaboration with AstraZeneca to En…
BOSTON, Sept. 22, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS's AI algorithms to detect genetic mutations in the PIK3CA/AKT1/PTEN pathway. The PIK3CA/AKT1/PTEN pathway is a key molecular signaling network tha
- 김갑성 기자
- 2025-09-22 20:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-21_TUE
- AESOP Technology announces DxPrime is now a qualified solution on Mayo Clinic Platform 23:30
- Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq 23:00
- Stéphane Rolland's Haute Couture to Illuminate the 10th Anniversary of Barcelona Bridal Night 23:00
- JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène 22:00
- AI meets capital: Bizcap welcomes 8fig into its global portfolio to accelerate growth funding 22:00
- Youth Innovation Safeguards Green Heritage: 2025 World Food Forum Youth Action on Green Agri-Heritage Held in Rome 21:00
- Vidu Launches Q2 "Reference-to-Video", Pioneering a New Era of High Consistency and Creative Control 21:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 22일 01시 00분